Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia

Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia

(2022) Antonio F. Pardiñas et al.   JAMA Psychiatry

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

(2022) Vassily Trubetskoy et al.   NATURE

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders

(2022) C. Okhuijsen-Pfeifer et al.   Translational Psychiatry

A comparison of ten polygenic score methods for psychiatric disorders applied across multiple cohorts

(2021) Guiyan Ni et al.   BIOLOGICAL PSYCHIATRY

Association of polygenic score for major depression with response to lithium in patients with bipolar disorder

(2020) Azmeraw T. Amare et al.   MOLECULAR PSYCHIATRY

Clozapina en pacientes con trastorno esquizoafectivo: una revisión sistemática

(2020) Diana Rey Souto et al.   Revista de Psiquiatria y Salud Mental

Phenome-wide and genome-wide analyses of quality of life in schizophrenia

(2020) Raha Pazoki et al.   BJPsych Open

Polygenic prediction via Bayesian regression and continuous shrinkage priors

(2019) Tian Ge et al.   Nature Communications

The genetics of the mood disorder spectrum: genome-wide association analyses of over 185,000 cases and 439,000 controls

(2019) Jonathan R.I. Coleman et al.   BIOLOGICAL PSYCHIATRY

Polygenic Risk Score for Schizophrenia and Treatment-Resistant Schizophrenia

(2017) Theresa Wimberley et al.   SCHIZOPHRENIA BULLETIN

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

(2009) Shaun M. Purcell et al.   NATURE